Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Healthcare
/
InMode
Create a narrative
InMode Community
NasdaqGS:INMD Community
3
Narratives
written by author
1
Comments
on narratives written by author
88
Fair Values set
on narratives written by author
Community Investing Ideas
InMode
Popular
Undervalued
Overvalued
InMode
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Aging Demographics And FDA Hurdles Will Shrink Demand
Key Takeaways Demographic shifts, regulatory hurdles, and cost-containment trends threaten InMode's market size, earnings predictability, and sustainable revenue growth. Heavy reliance on device sales and rising competition amplify earnings volatility, margin pressure, and risks tied to international expansion and distributor performance.
View narrative
US$14
FV
5.0% overvalued
intrinsic discount
-1.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
InMode
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Aging And Wellness Trends Will Boost Med Tech Amid Risks
Key Takeaways New wellness platform and likely regulatory clearances could unlock major, underserved medical markets, significantly expanding growth opportunities in devices and recurring revenue streams. Aggressive global expansion and shifting demographics are expected to drive sustained international growth, higher margins, and increasing profitability through premium product adoption and recurring sales.
View narrative
US$21
FV
30.0% undervalued
intrinsic discount
5.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
11 days ago
author updated this narrative
InMode
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expansion In Thailand And Argentina Will Boost Revenue Despite Risks
Key Takeaways Strategic expansion in emerging and European markets, along with new product launches, diversifies revenue and supports global growth. Focus on minimally invasive treatments and strong marketing boosts demand, market penetration, and maintains high profit margins.
View narrative
US$16.25
FV
9.5% undervalued
intrinsic discount
0.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
43
users have followed this narrative
18 days ago
author updated this narrative